LZI MULTIPLE ANALYTE SET A; B; C DRUGS OF ABUSE CONTROLS— 510(k) K133710
Substantially EquivalentLin-Zhi International, Inc.
FDA 510(k) clearance K133710 for LZI MULTIPLE ANALYTE SET A; B; C DRUGS OF ABUSE CONTROLS, Substantially Equivalent on 2014-02-21. Applicant: Lin-Zhi International, Inc.. Device class: 2.
Clearance details
- Device name as filed
- LZI MULTIPLE ANALYTE SET A;B;C DRUGS OF ABUSE CONTROLS
- Applicant
- Lin-Zhi International, Inc.
- Product code
- Code DKB
- Device class
- Class 2
- Regulation
- 21 CFR 862.3200
- Advisory panel
- Clinical Toxicology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Sunnyvale, CA, US
Recent devices under product code DKB
view all- K141928 — COBAS C ACETAMINOPHEN GEN.2 ASSAY, ACET2 CALIBRATOR
- K120936 — ABBOTT TDM MULTICONSTITUENT CALIBRATOR, THERMO SCIENTIFIC QMS MULTI-CONSTITUENT CALIBRATORS
- K092266 — RANDOX METHAMPHETAMINE ASSAY
- K101752 — THERMO SCIENTIFIC CEDIA MULTI-DRUG OFT CALIBRATORS
- K090939 — ROCHE C.F.A.S. DAT QUALITATIVE PLUS CLINICAL CALIBRATOR AND CONTROL SET DAT CLINICAL, MODELS 04590856 190, 04500873 190
More clearances from Lin-Zhi International, Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.